Some more info [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-17 22:28 (922 d 21:28 ago) – Posting: # 22587
Views: 5,692

Hi ElMaestro,

❝ One good question is what happens now. I would not be surprised if PanExcell and Synchron will cease to exist (might pop up under another name?), sponsors using the two CROs will be forced to abandon some/all of their MA's and/or repeat studies


Yes, indeed, in the USA: instructions to companies have now been posted on the FDA web site. Repeat all studies; therapeutic equivalence of already approved products is meanwhile changed to BX. Europe: it should not take them more than a year or two to decide what to do :sleeping:

❝ Have a look at the pdf files from FDA. Now answer this question: Which day were the letters issued?


❝ Do we really need to go looking for the date on the linking FDA page?


According to this new page: the letters were sent out on 15 September 2021.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
88 visitors (0 registered, 88 guests [including 8 identified bots]).
Forum time: 18:56 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5